Fungal infection in solid organ recipients

Area of Science:

• Medical Mycology
• Transplant Infectious Diseases
• Immunocompromised Host Infections

Background:

• Solid organ transplant recipients are highly susceptible to invasive fungal infections (mycoses).
• Candida and Aspergillus species are the most frequent pathogens, while others like Cryptococcus, Mucorales, Fusarium, and Scedosporium are less common but significant.
• Risk factors include immunosuppression, surgery, viral co-infections, and environmental exposure.

Purpose of the Study:

• To review the epidemiology, diagnosis, and management of invasive fungal infections in solid organ transplant recipients.
• To highlight the challenges in diagnosing these infections and the importance of timely treatment.
• To discuss the available antifungal agents and considerations for their administration.

Main Methods:

• Literature review of invasive fungal infections in solid organ transplant recipients.
• Analysis of common and uncommon fungal pathogens.
• Discussion of diagnostic modalities and their limitations.
• Overview of current antifungal therapies and treatment principles.

Main Results:

• Invasive mycoses are frequent in this population, with Candida and Aspergillus being most common.
• Diagnosis is difficult, with limited utility of blood cultures and antigen tests, necessitating empirical therapy.
• Delayed treatment significantly increases mortality.
• Treatment involves azoles, echinocandins, and lipid amphotericin, with administration guided by efficacy, drug interactions, and safety.

Conclusions:

• Invasive fungal infections pose a significant threat to solid organ transplant recipients.
• Prompt diagnosis and empirical antifungal therapy are essential due to diagnostic challenges and high mortality.
• Treatment selection requires careful consideration of antifungal spectrum, drug interactions, and patient-specific factors.